skip to Main Content
The First Natural Cannabis Plant Product To Be UK Validated As A Food Ingredient

AS the dust settles on the release of the UK Food Standards Agency’s first Public List of Validated Novel Food CBD applications, it’s fair to say that a significant milestone has been reached.

It passed under the radar initially, but what we have witnessed is the first ‘natural cannabis-based compound to have been validated as a food ingredient in the UK’.

In the European Union CBDepot synthesised CBD achieved this milestone in 2020, and Monday’s FSA announcement saw synthesised CBD from two suppliers achieve UK Validation.

However, Czech firm CBDepot – one of the companies to achieve a UK synthesised CBD validation this week –  has also achieved a significant cannabis industry first.

Milestone For Hemp Industry

Boris Baňas, founder and Chief Sales Officer of CBDepot said: “This is very important; a very significant milestone for the hemp Industry.

“We have now the first cannabis-based compound to have been validated for the risk assessment as a food ingredient.

“Our application for plant-based CBD in the EU has not been Validated yet, it may have passed the initial EFSA suitability stage, but it has not been Validated and passed on to scientific advisors for a risk assessment.

“So, for our natural plant CBD isolate to have reached this stage shows that natural plant extracts have a place in the UK food industry.”

Public List Updated Weekly

The FSA has said it will be updating the Regulated Products CBD Novel Food Public List on a weekly basis, with this process expected to be complete by June, it says.

Monday’s first public list included 23 products from two primary applicants, with synthesised CBD company Pureis CBD appearing alongside CBDepot with their R&D & brand partners 4MP and CBDex.

Pureis CBD validation features 11 products – a variety of drops, sprays and capsules.

Whilst 4MP, features 10 products including; chews, oils and sprays in concentrations from 5% to 15% CBD. CBDex included two natural plant isolate tinctures in concentrations of 5% and 10% CBD.

Scott Cooper, Director Product & Business Development, at 4MP Technologies said its appearance on this first iteration of the Public List ‘came as a complete shock’.

“We expected to fall under the radar with a further dozen-or-so other companies. To be on the Public List with a clean validation is quite an achievement.

Sporting CBD Range

“Our joint teams spent a lot of time developing the primary product offering, and a secondary product offering we plan to add to the Public List later in the year,” he added.

He went on to say 4MP is now looking to upscale its production capacity in the UK and continue to deliver on its amateur and professional sports-focused Pure CBD ranges, as well as CBD snack ranges such as granola bars and coated mixed nuts, seeds and fruits.

For its two base ingredients CBDepot had undertaken a full complement of Tier 1 and Tier 2 studies, and all of them required the necessary Genotoxicity, the Sub-chronic 90-day toxicity and Toxicokinetcs trials.

With UK Validation complete, its applications will now be passed on to the Food Standards Agency’s (FSA) scientific advisors for a safety assessment and if successful will be Authorised for sale on the UK market.

Mr Baňas said that its novel food consultants had found no evidence of CBD having any harmful effects based on the data it generated in 2020.

Although, he went on to say that its EFSA application was on voluntary hold until May, as it requires further information which will be shared with the UK FSA once available.

Peter McCusker

Peter McCusker

Peter McCusker is the Founder and Editor of BusinessCann and an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant. BusinessCann covers the ins and outs of the growing European Regulated Medical Marijuana marketplace. Peter can be reached at [email protected].

BusinessCann is an online news publication, which supports the growth of Europe’s Hemp, CBD and Medicinal Cannabis industries by providing factual and feature articles, comment and profiles on the people and businesses forging its growth and development.
This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

California’s legal weed industry can’t compete with illicit market

Local government opposition, high taxes and competition from unlicensed businesses are complicating the state’s push to build a thriving legal market. LOS ANGELES — California’s cannabis market is booming nearly five years after voters legalized recreational weed. But there’s a catch: the vast majority of pot sales are still underground. Rather than make cannabis a…

Europe’s First Adult-Use Cannabis Market Confirmed With Luxembourg Permitting Household Cultivation And Consumption

LUXEMBOURG is to become the first European country to permit adult-use cannabis after the Government announced measures to permit households to cultivate up to four domestic plants. The announcement, earlier today, applies to to all citizens over the age of 18 with the new regulations also allowing for the sale and import of seeds. However,…

Scientists Develop Quick Test for Marijuana Use

FRIDAY, Oct. 22, 2021 (HealthDay News) — Researchers may be one step closer to developing the equivalent of a Breathalyzer for detecting marijuana use. In an early study, scientists found that their rapid test was able to reliably detect THC in people’s saliva in under 5 minutes. THC, short for tetrahydrocannabinol, is the active ingredient…

Adult Use Cannabis and The Workplace

New York Labor Law 201-D This document is intended to address some of the most common situations or questions in the workplace related to adult-use cannabis and the Marijuana Regulation and Taxation Act (“MRTA”). This document does not address the medical use of cannabis. For further assistance with New York Labor Law and the MRTA, please…

More Categories

Back To Top
×Close search